Suraksha Diagnostic Limited — Updates, 08-08-2025: Press Release

Suraksha Diagnostic reported strong Q1 FY26 financial results with Total Income up 18.83% year-on-year to ₹73.49 Cr. EBITDA grew 13.51% to ₹24.66 Cr, while Profit After Tax increased 19.67% to ₹9.18 Cr. Key operational developments include the launch of Suraksha Genomics, a new vertical for cutting-edge genetic and molecular testing. The company also acquired a 63% stake in Fetomat Wellness, strengthening its presence in pregnancy and prenatal care, and expanded its footprint by adding three new centers.